Takehiro Hashikata

Effects on bone metabolism markers and arterial stiffness by switching to rivaroxaban from warfarin in patients with atrial fibrillation

S Namba, Minako Yamaoka‐Tojo, Ryota Kakizaki et al. · Heart and Vessels · 2017 · 51 citations

Thrombosis, Cardiovascular Disease, Atherosclerosis +15

Rivaroxaban Inhibits Angiotensin II-Induced Activation in Cultured Mouse Cardiac Fibroblasts Through the Modulation of NF-<i>κ</i>B Pathway

Takehiro Hashikata, Minako Yamaoka‐Tojo, S Namba et al. · International Heart Journal · 2015 · 50 citations · Full text

Cardiac Muscle, Heart Failure, Immunology +19

Long-term warfarin therapy and biomarkers for osteoporosis and atherosclerosis

S Namba, Minako Yamaoka‐Tojo, Takehiro Hashikata et al. · BBA Clinical · 2015 · 42 citations · Full text

Teneligliptin improves left ventricular diastolic function and endothelial function in patients with diabetes

Takehiro Hashikata, Minako Yamaoka‐Tojo, Ryota Kakizaki et al. · Heart and Vessels · 2015 · 37 citations

Metabolic Syndrome, Hypertension, Heart Failure +14

Factor Xa in Mouse Fibroblasts May Induce Fibrosis More Than Thrombin

Lisa Kitasato, Minako Yamaoka‐Tojo, Takehiro Hashikata et al. · International Heart Journal · 2014 · 28 citations · Full text

Immunology, Pathology, Cardiac Regeneration +21